- FoI Number
- 2023-399
- Subject
- Gastroenterology
- Date Received
- 05/10/2023
- Request and Response
-
- How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
NHS Shetland does not have a Gastroenterology Department
Adalimumab – Humira 2 Adalimumab Biosimilar 16 Filgotinib 0 Golimumab 0 Infliximab – Remicade 0 Infliximab Biosimilar 4 Mirikizumab 0 Ozanimod 0 Risankizumab 0 Tofacitinib 1 Upadacitinib 0 Ustekinumab 2 Vedolizumab 3 - If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs:
- Adalimumab - Humira
- Adalimumab Biosimilar
- Filgotinib
- Golimumab
- Infliximab - Remicade
- Infliximab Biosimilar
- Mirikizumab
- Ozanimod
- Risankizumab
- Tofacitinib
- Upadacitinib
- Ustekinumab
- Vedolizumab
In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland are unable to provide this level of detail.
